Scientific Advisory Committee

OCRA’s Scientific Advisory Committee (SAC) comprises renowned doctors and researchers in the field of gynecologic oncology who help determine which grants we fund. This panel of esteemed experts reviews hundreds of proposals annually, selecting the most innovative and promising.

Meet the SAC

Ronald D. Alvarez, MD, MBA, Chair

Vanderbilt University Medical Center

Deborah K. Armstrong, MD

Johns Hopkins School of Medicine

Robert C. Bast Jr., MD

MD Anderson Cancer Center

Andrew Berchuck, MD

Duke Comprehensive Cancer Center

Jonathan S. Berek, MD, MMS

Stanford University School of Medicine

Molly Brewer, DVM, MD, MS

University of Connecticut Health Center

Ronald Buckanovich, MD, PhD

Magee-Womens Research Institute

Kathleen Cho, MD

University of Michigan Medical School

Robert L. Coleman, MD

Vaniam Group

Oliver Dorigo, MD, PhD

Stanford University

Katherine Fuh, MD, PhD

University of California, San Francisco

Gillian Hanley, PhD

University of British Columbia

Gwen Harding-Peets, PhD

Patient Advocate

David Huntsman, MD, FRCPC, FCCMG

University of British Columbia

Beth Y. Karlan, MD

UCLA Medical Center

Dineo Khabele, MD

Washington University School of Medicine in St. Louis

Ursula Matulonis, MD, Grants Oversight Chair

Dana-Farber Cancer Institute

Kathleen Moore, MD, MS

University of Oklahoma Health Sciences Center

Kenneth Nephew, PhD

University of Indiana

Sandra Orsulic, PhD

David Geffen School of Medicine at the University of California, Los Angeles (UCLA)

Celeste Leigh Pearce, PhD, MPH

University of Michigan

Carolyn D. Runowicz, MD

Florida International University

Ie-Ming Shih, MD, PhD

Johns Hopkins University School of Medicine

Anil K. Sood, MD

MD Anderson Cancer Center

Shelley Tworoger, PhD

Oregon Health and Science Center

Jason D. Wright, MD

Columbia University Medical Center

Former Members

Jeff Boyd, PhD
Carmel J. Cohen, MD
Alan D. D’Andrea, MD
Ronny I. Drapkin, MD, PhD
Annie Ellis
Ellen L. Goode, PhD
Susan Leighton
Ernst Lengyel, MD, PhD
Douglas A. Levine, MD
Carolyn Muller, MD, FACOG
Kunle Odunsi, MD, PhD
Bob Ozols, MD, PhD
Daniel J. Powell Jr., PhD
Stephen C. Rubin, MD
Michael Seiden, MD, PhD
Elizabeth Swisher, MD

Related Topics

OCRA’s Online Seminar Shares Newest Information on Endometrial Cancer Biomarker Testing

Ovarian Cancer Research Alliance hosted a free online seminar on April 9th titled “Endometrial Cancer: Understanding Biomarker Testing & Its Value in the Changing Treatment Landscape.” Dr. Ramez Eskander of … Continued

The Overview: March 2025

Ovarian Cancer Research Alliance’s Vice President of Policy, Chad Ramsey, spoke with Ellen Bryan of WUSA-TV’s Great Day Washington, and shared important new findings from a paper co-authored by OCRA … Continued

Press Release: Nearly Half of Women With Ovarian Cancer Are Not Receiving Critical Genetic Testing

DISPARITIES IN TESTING RATES AMONG OLDER WOMEN AND THOSE ON PUBLIC INSURANCE PERSIST [New York, New York – March 25, 2025] – Nearly half of women diagnosed with ovarian cancer … Continued

Scientific Advisory Committee